Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Keyword(s):
Pancreatic ductal adenocarcinoma (PDAC) represents an aggressive tumor of the digestive system with still low five-year survival of less than 10%. Although there are improvements for multimodal therapy of PDAC, surgery still remains the effective way to treat the disease. Combined with adjuvant and/or neoadjuvant treatment, pancreatic surgery is able to enhance the five-year survival up to around 20%. However, pancreatic resection is always associated with a high risk of complications and regarded as one of the most complex fields in abdominal surgery. This review gives a summary on the surgical treatment for PDAC based on the current literature with a special focus on resection techniques.
2020 ◽
Vol 12
◽
pp. 175883592093303
◽
Keyword(s):
2019 ◽
Vol 89
(4)
◽
pp. 842-851.e1
◽
Keyword(s):
2019 ◽
Vol 26
(2)
◽
pp. 63-72
◽
Keyword(s):
2021 ◽
2020 ◽
Vol 21
(4)
◽
pp. 127-130